TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33177181

Group type: EXPERIMENTAL
Intervention: Hepatitis B surface antigen formulated with adjuvant AS01B
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hepatitis B surface antigen formulated with adjuvant AS01E
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hepatitis B surface antigen formulated with adjuvant AS03
Number of subjects: 0
Study: 35567630

Group type: EXPERIMENTAL
Intervention: 2% nitrilotriacetic acid trisodium salt
Number of subjects: 58

Group type: COMPARATOR
Intervention: 0.9% sodium chloride
Number of subjects: 58
Study: 32708864

Group type: EXPERIMENTAL
Intervention: Multidisciplinary residential nutritional rehabilitation program
Number of subjects: 71

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 71
Study: 34969004

Group type: EXPERIMENTAL
Intervention: Transversus abdominis plane (TAP) blocks with liposomal bupivacaine
Number of subjects: 498

Group type: COMPARATOR
Intervention: Epidural analgesia
Number of subjects: 498
Study: 33264769

Group type: EXPERIMENTAL
Intervention: Continuous venovenous hemofiltration (CVVH)
Number of subjects: 170

Group type: COMPARATOR
Intervention: All other modalities
Number of subjects: 170
Study: 33038007

Group type: EXPERIMENTAL
Intervention: Topical niacinamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35761212

Group type: EXPERIMENTAL
Intervention: Embedded individualised multicomponent frailty intervention (extra sessions of physiotherapy, pharmacy, and dietetics during admission)
Number of subjects: 732

Group type: EXPERIMENTAL
Intervention: Embedded individualised multicomponent frailty intervention
Number of subjects: 732
Study: 33226176

Group type: EXPERIMENTAL
Intervention: 1064-nm Nd:YAG laser
Number of subjects: 34

Group type: COMPARATOR
Intervention: 595-nm pulsed dye laser (PDL)
Number of subjects: 34
Study: 33736903

Group type: EXPERIMENTAL
Intervention: FAST
Number of subjects: 395

Group type: COMPARATOR
Intervention: Stroke-112
Number of subjects: 395
Study: 32589515

Group type: EXPERIMENTAL
Intervention: Bridge-enhanced ACL repair
Number of subjects: 65
Study: 32981857

Group type: EXPERIMENTAL
Intervention: Intrathecal ex vivo‐expanded WJ‐MSCs (10 × 10^6 cells)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 36416036

Group type: COMPARATOR
Intervention: InSurE
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: LISA
Number of subjects: 150
Study: 32259687

Group type: EXPERIMENTAL
Intervention: Portable Non-Invasive Ventilation (pNIV)
Number of subjects: 24
Study: 33412490

Group type: EXPERIMENTAL
Intervention: Collaborative task-sharing model with enhanced mental health training and lay counselling referral service
Number of subjects: 1043

Group type: COMPARATOR
Intervention: Care as usual (CAU) involving referral to PHC doctors and/or mental health specialists
Number of subjects: 1043
Study: 32342884

Group type: EXPERIMENTAL
Intervention: Tonic compression at the thigh with lower inflation pressures
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Phasic compression
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Tonic compression
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Circumferential compression with narrow connection cuffs
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Inflation pressures below 14 kPa
Number of subjects: 21
Study: 35568312

Group type: EXPERIMENTAL
Intervention: Active HD-tDCS (twice a day, 30-min, 3-mA) plus respiratory rehabilitation
Number of subjects: 56

Group type: COMPARATOR
Intervention: Sham HD-tDCS plus respiratory rehabilitation
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Active HD-tDCS
Number of subjects: 56

Group type: COMPARATOR
Intervention: Sham HD-tDCS
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Active HD-tDCS and Sham HD-tDCS
Number of subjects: 56
Study: 33855355

Group type: EXPERIMENTAL
Intervention: Intermittent two-drug regimens (2-DRs) given 4-5 days a week
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Resuming the same 2-DR 7 days a week
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Intermittent two-drug regimens (2-DRs)
Number of subjects: 85
Study: 36260786

Group type: EXPERIMENTAL
Intervention: Immediate treatment with 5-fluorouracil and folinic acid or capecitabine plus oxaliplatin (FOLFOX6 or CAPEOX; Arm 1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Serial ctDNA surveillance with delayed adjuvant therapy (Arm 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FOLFOX6/CAPEOX (Arm 3)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FOLFIRINOX (Arm 4)
Number of subjects: 0
Study: 34588245

Group type: EXPERIMENTAL
Intervention: eMMa (electronic medication management support system)
Number of subjects: 17200
Study: 32041881

Group type: EXPERIMENTAL
Intervention: Δ9‐tetrahydrocannabinol (THC) intoxication
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 64
Study: 36288581

Group type: EXPERIMENTAL
Intervention: Web-based CBT with 6 phone calls (nurse support group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Web-based CBT alone (control group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nurse support group
Number of subjects: 60
Study: 33824389

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 36038003

Group type: EXPERIMENTAL
Intervention: Tanezumab 10 mg subcutaneously
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 34606933

Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 33190355

Group type: EXPERIMENTAL
Intervention: Protein intake at breakfast (10 g increase)
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: Protein intake at lunch (10 g increase)
Number of subjects: 498
Study: 32962950

Group type: EXPERIMENTAL
Intervention: Cannulated screws (CS)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Screw plus reconstruction plate (SpRP)
Number of subjects: 63
Study: 36112574

Group type: EXPERIMENTAL
Intervention: HIV-unexposed children
Number of subjects: 1920

Group type: COMPARATOR
Intervention: HIV-exposed children
Number of subjects: 1920

Group type: EXPERIMENTAL
Intervention: WGCFM score increase
Number of subjects: 1920
Study: 34152666

Group type: EXPERIMENTAL
Intervention: Portable accelerometer‐based navigation devices (PAD)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Conventional instrumentation (CON)
Number of subjects: 178
Study: 36468897

Group type: EXPERIMENTAL
Intervention: Biliary stent loaded with radioactive 125 I seeds (RBS)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Conventional biliary stent (CBS)
Number of subjects: 196
Study: 32938772

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 18140

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 18140

Group type: EXPERIMENTAL
Intervention: All patients post-discontinuation (≤30 days)
Number of subjects: 18140
Study: 34491446

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgical technique (MIST) or modified minimally invasive surgical technique (M-MIST)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Modified or simplified papilla preservation (MPP) or simplified papilla preservation technique (SPP)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Early healing index (EHI) score
Number of subjects: 47
Study: 616661423

Group type: EXPERIMENTAL
Intervention: e-learning
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: curriculum-based self-study
Number of subjects: 244

Group type: COMPARATOR
Intervention: seminar
Number of subjects: 244

Group type: COMPARATOR
Intervention: lecture
Number of subjects: 244
Study: 33356401

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 4796

Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 4796
Study: 32436409

Group type: EXPERIMENTAL
Intervention: Unilateral Uvuloplasty after Primary Palatoplasty
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Method for uvular repair during primary palatoplasty
Number of subjects: 0
Study: 34996343

Group type: EXPERIMENTAL
Intervention: Transdiagnostic behavior therapy (TBT)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Behavioral activation (BA)
Number of subjects: 93
Study: 33755280

Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 91
Study: 32379711

Group type: EXPERIMENTAL
Intervention: Self-preventive care among TB patients
Number of subjects: 1600

Group type: EXPERIMENTAL
Intervention: Awareness and attitudes towards TB
Number of subjects: 1600
Study: 35410753

Group type: EXPERIMENTAL
Intervention: SID142 (200 mg cilostazol and 160 mg Ginkgo biloba leaf extract, once daily)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Renexin (cilostazol and Ginkgo biloba leaf extract, twice daily)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: SID142
Number of subjects: 170
Study: 32780155

Group type: EXPERIMENTAL
Intervention: Ahlbäck classification
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Kellgren-Lawrence classification
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: International Knee Documentation Committee (IKDC) classification
Number of subjects: 112
Study: 32730216

Group type: EXPERIMENTAL
Intervention: RTSU-Net (relational approach with a novel non-local neural network module)
Number of subjects: 5470
Study: 35131363

Group type: EXPERIMENTAL
Intervention: Vortioxetine 5 mg
Number of subjects: 1106

Group type: EXPERIMENTAL
Intervention: Vortioxetine 10 mg
Number of subjects: 1106

Group type: EXPERIMENTAL
Intervention: Vortioxetine 20 mg
Number of subjects: 1106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1106
Study: 33794293

Group type: EXPERIMENTAL
Intervention: Plasma tumor DNA detection
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: TP53 gene alteration pre-treatment and at C2D1
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: RB1 gene alteration pre-treatment and at C2D1
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: PTEN gene alteration pre-treatment and at C2D1
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Patients who were positive pre-treatment and converted to undetectable
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Progression samples with AR gain
Number of subjects: 151
Study: 33338360

Group type: EXPERIMENTAL
Intervention: Lower socioeconomic status (SES)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower income and occupational class
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher education and higher income
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower education
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SES variables
Number of subjects: 0
Study: 36126310

Group type: EXPERIMENTAL
Intervention: Laparoscopic complete fundoplication (LNF)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Laparoscopic partial fundoplication (LTF)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Control group (LTF)
Number of subjects: 175
Study: 32046384

Group type: EXPERIMENTAL
Intervention: Metformin (MET)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 8
Study: 35557278

Group type: EXPERIMENTAL
Intervention: BAPN (300 mg/kg/day in water)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 8
Study: 32760097

Group type: EXPERIMENTAL
Intervention: Motor-control group (integrated motor control techniques with scapular strengthening exercises)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Regular-exercise group (conventional physical therapy and scapular muscle strengthening exercises)
Number of subjects: 38
Study: 36109008

Group type: EXPERIMENTAL
Intervention: Sodium Citrate (SC, 500 mg/kg body mass)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sodium Bicarbonate (SB, 300 mg/kg body mass)
Number of subjects: 16
Study: 35665794

Group type: EXPERIMENTAL
Intervention: Complete handover of anesthesia care to another clinician (n=908)
Number of subjects: 1817

Group type: COMPARATOR
Intervention: No handover of anesthesia care (n=909)
Number of subjects: 1817

Group type: EXPERIMENTAL
Intervention: Complete handover of anesthesia care
Number of subjects: 1817

Group type: COMPARATOR
Intervention: No handover of anesthesia care
Number of subjects: 1817
Study: 32827501

Group type: EXPERIMENTAL
Intervention: Intranasal AVP (20 IU)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 36131289

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive therapy (iCBT) involving 7 weekly online modules delivered via a perinatal mental healthcare app
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive therapy (iCBT)
Number of subjects: 300
Study: 34264766

Group type: EXPERIMENTAL
Intervention: 10.6 μm laser moxibustion (LM)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Traditional moxibustion (TM)
Number of subjects: 92
Study: 35707385

Group type: EXPERIMENTAL
Intervention: Theory-based educational intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 32810383

Group type: EXPERIMENTAL
Intervention: 20 mg teneligliptin
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study: 35960044

Group type: EXPERIMENTAL
Intervention: Lidocaine (1 mg/kg intravenously during anesthesia induction, then continuously pumped at 1 mg/kg/h until operation)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (normal saline of equal volume)
Number of subjects: 40
Study: 33548442

Group type: EXPERIMENTAL
Intervention: Percutaneous arteriovenous fistulas (p‐AVFs) created with the Ellipsys device
Number of subjects: 214

Group type: COMPARATOR
Intervention: Surgical arteriovenous fistulas (s‐AVFs)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Percutaneous arteriovenous fistulas (p‐AVFs)
Number of subjects: 214
Study: 32039635

Group type: EXPERIMENTAL
Intervention: Brief Behavioral Therapy for Insomnia (BBTi)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Self-Monitoring Control (SMC)
Number of subjects: 62

Group type: COMPARATOR
Intervention: BBTi and SMC
Number of subjects: 62
Study: 34320713

Group type: COMPARATOR
Intervention: Dexketoprofen
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Tamsulosin
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Silodosin
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Tadalafil
Number of subjects: 193
Study: 32663974

Group type: EXPERIMENTAL
Intervention: Real rTMS
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 31
Study: 36163987

Group type: EXPERIMENTAL
Intervention: Pacritinib (PAC) 200mg BID
Number of subjects: 106

Group type: COMPARATOR
Intervention: Ruxolitinib (RUX)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Pacritinib (PAC)
Number of subjects: 106
Study: 34232106

Group type: EXPERIMENTAL
Intervention: Outpatient physician visit-days
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Laboratory visit-days
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Combined radiology visit-days
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Year of SSc diagnosis
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Rate ratios for outpatient services
Number of subjects: 69

Group type: COMPARATOR
Intervention: Non-SSc comparators
Number of subjects: 69
Study: 33327231

Group type: EXPERIMENTAL
Intervention: CT angiogram (CTA) group (n=20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mimics group (n=20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: CTA + mimics group (n=20)
Number of subjects: 60
Study: 34533774

Group type: EXPERIMENTAL
Intervention: Baseline iron deficiency
Number of subjects: 2141

Group type: EXPERIMENTAL
Intervention: Iron deficiency at any yearly time point
Number of subjects: 2141
Study: 33347383

Group type: EXPERIMENTAL
Intervention: Pinto bean snack
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Chickpea snack
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control snack (100% corn)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Whole yellow pea snack
Number of subjects: 26

Group type: COMPARATOR
Intervention: Green lentil snack
Number of subjects: 26

Group type: COMPARATOR
Intervention: Split yellow pea snack
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: All snacks
Number of subjects: 26
Study: 33513520

Group type: EXPERIMENTAL
Intervention: BRIMMS visual
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: BRIMMS aural
Number of subjects: 24

Group type: COMPARATOR
Intervention: Usual consultations
Number of subjects: 24
Study: 33246430

Group type: EXPERIMENTAL
Intervention: Alberta FICare™ (n = 353 infants/308 mothers)
Number of subjects: 765

Group type: COMPARATOR
Intervention: Standard care (n = 365 infants/306 mothers)
Number of subjects: 765

Group type: EXPERIMENTAL
Intervention: Alberta FICare™
Number of subjects: 765

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 765
Study: 35897097

Group type: EXPERIMENTAL
Intervention: Modified procedure (30 patients)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Conventional Bricker ileal conduit (54 patients)
Number of subjects: 84
Study: 33605982

Group type: EXPERIMENTAL
Intervention: Soft drusen volume in AMD eyes assessed by OCT
Number of subjects: 44

Group type: COMPARATOR
Intervention: Cone density in donor eyes
Number of subjects: 44

Group type: COMPARATOR
Intervention: Macular pigment optical density (MPOD)
Number of subjects: 44
Study: 32188425

Group type: EXPERIMENTAL
Intervention: Watchful observation (no PCI)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Stereotactic radiotherapy (SRT) or whole brain radiotherapy (WBRT) for patients who develop brain metastases
Number of subjects: 80
Study: 35508338

Group type: EXPERIMENTAL
Intervention: Sodium valproate 20 mg/kg daily
Number of subjects: 182

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 182
Study: 32038026

Group type: EXPERIMENTAL
Intervention: Biodegradable polymer sirolimus-eluting stent (BP-SES)
Number of subjects: 2737

Group type: COMPARATOR
Intervention: Durable polymer sirolimus-eluting stent (DP-SES)
Number of subjects: 2737

Group type: EXPERIMENTAL
Intervention: Six-month dual antiplatelet therapy (DAPT) after BP-SES implantation
Number of subjects: 2737

Group type: COMPARATOR
Intervention: Twelve-month dual antiplatelet therapy (DAPT) after BP-SES implantation
Number of subjects: 2737
Study: 34375541

Group type: EXPERIMENTAL
Intervention: Polymorphic SSRs identified and validated using e‐PCR and capillary electrophoresis.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetic diversity analysis using polymorphic SSRs.
Number of subjects: 0
Study: 32173896

Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy
Number of subjects: 192

Group type: COMPARATOR
Intervention: Controls (n = 145)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Patients with major depressive disorder
Number of subjects: 192
Study: 36386386

Group type: EXPERIMENTAL
Intervention: Nabiximols oromucosal spray
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 32544773

Group type: EXPERIMENTAL
Intervention: Audio-visual stimuli
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Testosterone (T)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Cortisol (C)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Testosterone x Cortisol interaction
Number of subjects: 282
Study: 35171041

Group type: EXPERIMENTAL
Intervention: Homeopathic Hypericum C200 in addition to usual pain management
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo in addition to usual pain management
Number of subjects: 0
Study: 32036764

Group type: EXPERIMENTAL
Intervention: Incremental risk format
Number of subjects: 321

Group type: COMPARATOR
Intervention: Total risk format
Number of subjects: 321
Study: 35416361

Group type: EXPERIMENTAL
Intervention: LF3-4 biomarker based on serum phosphopeptide profiling
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Double-blind validation of LF3-4 biomarker
Number of subjects: 60
Study: 33390054

Group type: EXPERIMENTAL
Intervention: Genetically predicted systolic blood pressure (per 10 mm Hg)
Number of subjects: 375256

Group type: EXPERIMENTAL
Intervention: Genetically predicted diastolic blood pressure (per 5 mm Hg)
Number of subjects: 375256
Study: 35618379

Group type: EXPERIMENTAL
Intervention: Nuffield Early Language Intervention (NELI) program, 20-week duration
Number of subjects: 1173

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 1173
Study: 33740757

Group type: COMPARATOR
Intervention: 5-cm EVD tunnel length (group A)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: 10-cm EVD tunnel length (group B)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: 15-cm EVD tunnel length (group C)
Number of subjects: 105
Study: 32447799

Group type: EXPERIMENTAL
Intervention: EVOO-enriched diet
Number of subjects: 33
Study: 33540180

Group type: EXPERIMENTAL
Intervention: Active cycle of breathing technique
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study: 32522198

Group type: EXPERIMENTAL
Intervention: Early intravenous metoprolol
Number of subjects: 191

Group type: COMPARATOR
Intervention: Control group (no metoprolol)
Number of subjects: 191
Study: 34895792

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 124
Study: 33852720

Group type: EXPERIMENTAL
Intervention: Tesamorelin
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 35139908

Group type: EXPERIMENTAL
Intervention: tofacitinib 5 mg BID
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: tofacitinib 10 mg BID
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: adalimumab 40 mg every 2 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo switching to tofacitinib 5 mg BID
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo switching to tofacitinib 10 mg BID
Number of subjects: 0

Group type: COMPARATOR
Intervention: other groups (tofacitinib 10 mg BID, adalimumab)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: tofacitinib/adalimumab groups
Number of subjects: 0
Study: 33871602

Group type: EXPERIMENTAL
Intervention: DASH diet intervention
Number of subjects: 0
Study: 35276669

Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy
Number of subjects: 645

Group type: COMPARATOR
Intervention: Postoperative chemoradiotherapy (CRT)
Number of subjects: 645

Group type: EXPERIMENTAL
Intervention: Baseline HRQoL measures (social functioning, nausea, WHO performance status, histologic subtype)
Number of subjects: 645